Cepheid (NASDAQ: CPHD) said Monday the pharmaceutical company received special Food and Drug Administration authorization to market a test that can detect swine flu in less than one hour.
The company said the FDA granted emergency use authorization to sell the Xpert Flu test, which can identify the 2009 strain of swine flu in under 60 minutes. The special authorization allows the test to be used in hospitals.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
The test has not been approved by the FDA and is only authorized to be used until April 26 under the emergency use designation.
Shares of Cepheid fell 2 cents to $12.46 in morning trading.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
